drugset / Trial / NCT00066651
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
Open-labelTreatment
Summary
RATIONALE: Immunotoxins can locate tumor cells and kill them without harming normal cells. Immunotoxin therapy may be effective in treating advanced solid tumors. PURPOSE: This phase I trial is studying the side effects and best dose of immunotoxin therapy in treating patients with recurrent unresectable advanced solid tumors.
Timeline
- Start
- 2003-07
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SS1(dsFv)-PE38 immunotoxin | Unknown | — | Intravenous |